CTRI/2019/05/018990CompletedPhase 4
A comparative study of the safety, efficacy, quality of life outcome and pharmacoeconomics of levetiracetam with controlled-release carbamazepine in patients of new onset focal seizures
Institutional sponsored0 sites74 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- Enrollment
- 74
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •The study will include all the newly diagnosed consenting adult patients of focal seizures without any other co-morbidities
Exclusion Criteria
- •Patients not willing to give written informed consent.
- •Pregnant females.
- •Patients already on treatment with study drugs.
- •Patients of seizures others than focal seizures.
- •Patients of head trauma within past one month.
- •Patients with known contraindication or refractoriness to study drugs.
Investigators
Similar Trials
Recruiting
Phase 4
Comparison of the efficacy and safety of tamsulosin OCAS with tamsulosin MR and placebo in improving lower urinary tract symptomsIRCT20100817004582N8rology Research Centre, Guilan University of Medical Sciences260
Not yet recruiting
Not Applicable
se of Baska mask versus Ambu-aura gain in adult patients undergoing elective surgery under general anaesthesia : A comparative study.CTRI/2022/07/044255Dr Shalini A
Completed
Phase 2
A comparative study to assess the safety and efficacy of underwater EMR for intermediate size (10-20 mm) colorectal polyps.JPRN-UMIN000018989Osaka international cancer institute230
Active, not recruiting
Not Applicable
Dexmedetomedine intravenous sedation on patients with and without Beta blockersCTRI/2018/08/015387ETHRADHAMA SUPER SPECIALITY EYE HOSPITA
Recruiting
Phase 2
evaluation the effect of botulinum toxin type A for treating frown linesskin rejuvenation.IRCT20150101020514N8Imen vaccine alborz Company140